Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,738 | -4,613 | -2,622 | -1,320 | -5,482 |
| Depreciation Amortization | 93 | 77 | 51 | 25 | 89 |
| Accounts payable and accrued liabilities | 1,101 | 83 | -103 | -293 | 188 |
| Other Working Capital | 1,877 | -219 | -177 | -332 | 441 |
| Other Operating Activity | -1,058 | -58 | 123 | 234 | -37 |
| Operating Cash Flow | $-7,725 | $-4,730 | $-2,728 | $-1,686 | $-4,801 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -6 | -6 | -3 | -4 |
| Investing Cash Flow | $-19 | $-6 | $-6 | $-3 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 50,894 | 49,644 | 6,061 | N/A | 7,281 |
| Other Financing Activity | -2,442 | -2,176 | -649 | 0 | -721 |
| Financing Cash Flow | $48,452 | $47,468 | $5,412 | $N/A | $6,560 |
| Beginning Cash Position | 8,363 | 8,363 | 8,363 | 8,363 | 6,608 |
| End Cash Position | 49,071 | 51,095 | 11,041 | 6,674 | 8,363 |
| Net Cash Flow | $40,708 | $42,732 | $2,678 | $-1,689 | $1,755 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,725 | -4,730 | -2,728 | -1,686 | -4,801 |
| Capital Expenditure | -19 | -6 | -6 | -3 | -4 |
| Free Cash Flow | -7,744 | -4,736 | -2,734 | -1,689 | -4,805 |